Most peptide therapies address symptoms of aging, but Epithalon potentially addresses one of its root causes at the cellular level
Results vary based on your age, your current health status, and your environmental exposures
Chem Pharm Bull 61(3):258272 Nakanishi K, Tajima F, Nakamura A, Yagura S, Ookawara T, Yamashita H, Suziki K, Taniguchi N, Ohno H (1995) Antioxidant system in hypobaric-hypoxia
IGF-1 LR3 is a favorite for boosting athletic performance
Development of a sustained delivery for LH-RH analogs Since daily injections of LH-RH analogs were inconvenient and occasionally produced compliance problems, in 1984 we developed a long-acting delivery system for the agonist [d-Trp6]-LH-RH in microcapsules of poly (DL-lactide-co-glycolide) (PLG) designed to release a controlled dose of the peptide over a 30-day period 15